Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 25 results.
User Information
Export Records
  1. 1.   Plasmacytoid dendritic cells sense HIV replication before detectable viremia following treatment interruption
  2. Mitchell, Julie L.; Takata, Hiroshi; Muir, Roshell; Colby, Donn J.; Kroon, Eugene; Crowell, Trevor A.; Sacdalan, Carlo; Pinyakorn, Suteeraporn; Puttamaswin, Suwanna; Benjapornpong, Khunthalee; Trichavaroj, Rapee; Tressler, Randall L.; Fox, Lawrence; Polonis, Victoria R.; Bolton, Diane L.; Maldarelli,Frank; Lewin, Sharon R.; Haddad, Elias K.; Phanuphak, Praphan; Robb, Merlin L.; Michael, Nelson L.; de Souza, Mark; Phanuphak, Nittaya; Ananworanich, Jintanat; Trautmann, Lydie
  3. JOURNAL OF CLINICAL INVESTIGATION. 2020, JUN 1; 130(6): 2845-2858.
  1. 2.   Next-generation in situ hybridization approaches to define and quantify HIV and SIV reservoirs in tissue microenvironments
  2. Deleage, Claire; Chan, Chi N.; Busman-Sahay, Kathleen; Estes, Jake
  3. Retrovirology. 2018, Jan 9; 15(1): 4.
  1. 3.   IL4 from T Follicular Helper Cells Downregulates Antitumor Immunity
  2. Shirota, Hidekazu; Klinman, Dennis; Ito, Shuku-ei; Ito, Hiroyasu; Kubo, Masato; Ishioka, Chikashi
  3. CANCER IMMUNOLOGY RESEARCH. 2017, Jan; 5(1): 61-71.
  1. 4.   FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer
  2. Watkins, S. K.; Zhu, Z. Q.; Riboldi, E.; Shafer-Weaver, K. A.; Stagliano, K. E. R.; Sklavos, M. M.; Ambs, S.; Yagita, H.; Hurwitz, A. A.
  3. Journal of Clinical Investigation. 2011, Apr; 121(4): 1361-1372.
  1. 5.   Downregulation of Robust Acute Type I Interferon Responses Distinguishes Nonpathogenic Simian Immunodeficiency Virus (SIV) Infection of Natural Hosts from Pathogenic SIV Infection of Rhesus Macaques
  2. Harris, L. D.; Tabb, B.; Sodora, D. L.; Paiardini, M.; Klatt, N. R.; Douek, D. C.; Silvestri, G.; Muller-Trutwin, M.; Vasile-Pandrea, I.; Apetrei, C.; Hirsch, V.; Lifson, J.; Brenchley, J. M.; Estes, J. D.
  3. Journal of Virology. 2010, Aug; 84(15): 7886-7891.
  1. 6.   Adaptive control of innate immunity
  2. Shanker, A.
  3. Immunology Letters. 2010, Jul; 131(2): 107-112.
  1. 7.   Noninvasive in vivo imaging of CD4 cells in simian-human immunodeficiency virus (SHIV)-infected nonhuman primates
  2. Di Mascio, M.; Paik, C. H.; Carrasquillo, J. A.; Maeng, J. S.; Jang, B. S.; Shin, I. S.; Srinivasula, S.; Byrum, R.; Neria, A.; Kopp, W.; Catalfamo, M.; Nishimura, Y.; Reimann, K.; Martin, M.; Lane, H. C.
  3. Blood. 2009 114(2): 328-337.
  1. 8.   Evaluation of the Pathogenesis of Decreasing CD4(+) T Cell Counts in Human Immunodeficiency Virus Type 1-Infected Patients Receiving Successfully Suppressive Antiretroviral Therapy
  2. Nies-Kraske, E.; Schacker, T. W.; Condoluci, D.; Orenstein, J.; Brenchley, J.; Fox, C.; Daucher, M.; Dewar, R.; Urban, E.; Hill, B.; Guenaga, J.; Hoover, S.; Maldarelli, F.; Hallahan, C. W.; Horn, J.; Kottilil, S.; Chun, T. W.; Folino, M.; Palmer, S.
  3. Journal of Infectious Diseases. 2009 199(11): 1648-1656.
  1. 9.   Plasmacytoid dendritic cells mediate oral tolerance
  2. Goubier, A.; Dubois, B.; Gheit, H.; Joubert, G.; Villard-Truc, F.; Asselin-Paturel, C.; Trinchieri, G.; Kaiserlian, D.
  3. Immunity. 2008 29(3): 464-475.
  1. 10.   HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism
  2. Manches, O.; Munn, D.; Fallahi, A.; Lifson, J.; Chaperot, L.; Plumas, J.; Bhardwaj, N.
  3. Journal of Clinical Investigation. 2008 118(10): 3431-3439.
  1. 11.   Peyer patches are not required for acute graft-versus-host disease after myeloablative conditioning and murine allogeneic bone marrow transplantation
  2. Welniak, L. A.; Kuprash, D. V.; Tumanov, A. V.; Panoskaltsis-Mortari, A.; Blazar, B. R.; Sun, K.; Nedospasov, S. A.; Murphy, W. J.
  3. Blood. 2006, JAN 1; 107(1): 410-412.
  1. 12.   Triptolide, a constituent of immunosuppressive Chinese herbal medicine, is a potent suppressor of dendritic-cell maturation and trafficking
  2. Chen, X.; Murakami, T.; Oppenheim, J. J.; Howard, O. M. Z.
  3. Blood. 2005, OCT 1; 106(7): 2409-2416.
  1. 13.   Provision of granulocyte-macrophage colony-stimulating factor converts an autoimmune response to a self-antigen into an antitumor response
  2. Ji, Q. Y.; Gondek, D.; Hurwitz, A. A.
  3. Journal of Immunology. 2005, AUG 1; 175(3): 1456-1463.
  1. 14.   Dendritic cells endocytose Bacillus anthracis spores: Implications for anthrax pathogenesis
  2. Brittingham, K. C.; Ruthel, G.; Panchal, R. G.; Fuller, C. L.; Ribot, W. J.; Hoover, T. A.; Young, H. A.; Anderson, A. O.; Bavari, S.
  3. Journal of Immunology. 2005, MAY 1; 174(9): 5545-5552.
  1. 15.   Novel tumor necrosis factor-knockout mice that lack Peyer's patches
  2. Kuprash, D. V.; Tumanov, A. V.; Liepinsh, D. J.; Koroleva, E. P.; Drutskaya, M. S.; Kruglov, A. A.; Shakhov, A. N.; Southon, E.; Murphy, W. J.; Tessarollo, L.; Grivennikov, S. L.; Nedospasov, S. A.
  3. European Journal of Immunology. 2005, MAY; 35(5): 1592-1600.
  1. 16.   Intra- and intercellular variations in the repair efficiency of O-6-methylguanine, and their contribution to kinetic complexity
  2. Souliotis, V. L.; Sfikakis, P. P.; Anderson, L. M.; Kyrtopoulos, S. A.
  3. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis. 2004, DEC 21; 568(2): 155-170.
  1. 17.   Macaque dendritic cells infected with SIV-recombinant canarypox ex vivo induce SIV-specific immune responses in vivo
  2. Villamide-Herrera, L.; Ignatius, R.; Eller, M. A.; Wilkinson, K.; Griffin, C.; Mehlhop, E.; Jones, J.; Han, S. Y.; Lewis, M. G.; Parrish, S.; Vancott, T. C.; Lifson, J. D.; Schlesinger, S.; Mascola, J. R.; Pope, M.
  3. Aids Research and Human Retroviruses. 2004, AUG; 20(8): 871-884.
  1. 18.   Real-time gap ligase chain reaction: A rapid semiquantitative assay for detecting p53 mutation at low levels in surgical margins and lymph nodes from resected lung and head and neck tumors
  2. Harden, S. V.; Thomas, D. C.; Benoit, N.; Minhas, K.; Westra, W. H.; Califano, J. A.; Koch, W.; Sidransky, D.
  3. Clinical Cancer Research. 2004 10(7): 2379-2385.
  1. 19.   Genetic control of myreloproliferation in BXH-2 mice
  2. Turcotte, K.; Gauthier, S.; Mitsos, L. M.; Shustik, C.; Copeland, N. G.; Jenkins, N. A.; Fournet, J. C.; Jolicoeur, P.; Gros, P.
  3. Blood. 2004 103(6): 2343-2350.
  1. 20.   A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV- speeific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 Rhesus macaques
  2. Malkevitch, N.; Patterson, L. J.; Aldrich, K.; Richardson, E.; Alvord, W. G.; Robert-Guroff, M.
  3. Journal of Immunology. 2003 170(8): 4281-4289.
  1. 21.   Presentation of exogenous whole inactivated simian immunodeficiency virus by mature dendritic cells induces CD4(+) and CD8(+) T-Cell responses
  2. Frank, I.; Santos, J. J.; Mehlhop, E.; Villamide-Herrera, L.; Santisteban, C.; Gettie, A.; Ignatius, R.; Lifson, J. D.; Pope, M.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2003 34(1): 7-19.
  1. 22.   Human dendritic cells express functional formyl peptide receptor-like-2 (FPRL2) throughout maturation
  2. Yang, D.; Chen, Q.; Gertz, B.; He, R.; Phulsuksombati, M.; Ye, R. D.; Oppenheim, J. J.
  3. Journal of Leukocyte Biology. 2002 72(3): 598-607.
  1. 23.   Interleukin-7 restores immunity in athymic T-cell-depleted hosts
  2. Fry, T. J.; Christensen, B. L.; Komschlies, K. L.; Gress, R. E.; Mackall, C. L.
  3. Blood. 2001 97(6): 1525-1533.
  1. 24.   Engagement of the OX-40 receptor in vivo enhances antitumor immunity
  2. Weinberg, A. D.; Rivera, M. M.; Prell, R.; Morris, A.; Ramstad, T.; Vetto, J. T.; Urba, W. J.; Alvord, G.; Bunce, C.; Shields, J.
  3. Journal of Immunology. 2000 164(4): 2160-2169.
  1. 25.   Infection With Human Immunodeficiency Virus Type 1 Upregulates Dna Methyltransferase, Resulting in De Novo Methylation of the Gamma Interferon (Ifn-Gamma) Promoter and Subsequent Downregulation of Ifn-Gamma Production
  2. Mikovits, J. A.; Young, H. A.; Vertino, P.; Issa, J. P. J.; Pitha, P. M.; Turcoskicorrales, S.; Taub, D. D.; Petrow, C. L.; Baylin, S. B.; Ruscetti, F. W.
  3. Molecular and Cellular Biology. 1998 18(9): 5166-5177.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel